Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU, Oztop I, Yazici O, Ozatli T, Inal A, Günaydın Y, Alici S, Demirci U, Cinkir HY, Aktas B, Aslan K, Uncu D, Yilmaz AU, Oksuzoglu B, Buyukberber S. Unal OU, et al. Among authors: buyukberber s. Oncol Res Treat. 2014;37(6):332-8. doi: 10.1159/000362857. Epub 2014 May 19. Oncol Res Treat. 2014. PMID: 24903764 Clinical Trial.
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).
Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Kaplan MA, et al. Among authors: buyukberber s. Oncology. 2012;83(3):141-50. doi: 10.1159/000338782. Epub 2012 Jul 18. Oncology. 2012. PMID: 22814315
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Demirci U, Tufan G, Aktas B, Balakan O, Alacacioglu A, Dane F, Engin H, Kaplan MA, Gunaydin Y, Ozdemir NY, Tugba Unek I, Karaca H, Akman T, Sonmez OU, Coskun U, Harputluoglu H, Sevinc A, Tonyali O, Buyukberber S, Benekli M. Demirci U, et al. Among authors: buyukberber s. J Cancer Res Clin Oncol. 2013 May;139(5):829-35. doi: 10.1007/s00432-013-1390-8. Epub 2013 Feb 12. J Cancer Res Clin Oncol. 2013. PMID: 23400732
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology.
Gumusay O, Coskun U, Akman T, Ekinci AS, Kocar M, Erceleb OB, Yazıcı O, Kaplan MA, Berk V, Cetin B, Taskoylu BY, Yildiz A, Goksel G, Alacacioglu A, Demirci U, Algin E, Uysal M, Oztop I, Oksuzoglu B, Dane F, Gumus M, Buyukberber S. Gumusay O, et al. Among authors: buyukberber s. J Cancer Res Clin Oncol. 2014 Jan;140(1):151-7. doi: 10.1007/s00432-013-1553-7. Epub 2013 Nov 29. J Cancer Res Clin Oncol. 2014. PMID: 24292400
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology.
Berk V, Kaplan MA, Tonyali O, Buyukberber S, Balakan O, Ozkan M, Demirci U, Ozturk T, Bilici A, Tastekin D, Ozdemir N, Unal OU, Oflazoglu U, Turkmen E, Erdogan B, Uyeturk U, Oksuzoglu B, Cinkir HY, Yasar N, Gumus M. Berk V, et al. Among authors: buyukberber s. Asian Pac J Cancer Prev. 2013;14(12):7367-9. doi: 10.7314/apjcp.2013.14.12.7367. Asian Pac J Cancer Prev. 2013. PMID: 24460304 Free article.
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Yildiz R, et al. Among authors: buyukberber s. J Oncol Pharm Pract. 2010 Sep;16(3):173-8. doi: 10.1177/1078155209347402. Epub 2009 Oct 15. J Oncol Pharm Pract. 2010. PMID: 19833685
Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology.
Kucukoner M, Isikdogan A, Arpaci E, Bilici M, Uncu D, Cetin B, Dane F, Inane M, Kaplan MA, Cayir K, Yetisyigit T, Ozdemir N, Inal A, Aksoy S, Alkis N, Tekin SB, Eroglu C, Turhal S, Benekli M, Buyukberber S. Kucukoner M, et al. Among authors: buyukberber s. Hepatogastroenterology. 2012 Oct;59(119):2343-7. doi: 10.5754/hge11709. Hepatogastroenterology. 2012. PMID: 22389301
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer.
Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Oksuzoglu B, Ozdemir NY, Yazilitas D, Benekli M, Uner A, Yamac D, Demirci U, Yildiz R, Karaca H, Unal OU, Bal O, Gumus M, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: buyukberber s. J Cancer Res Clin Oncol. 2012 Dec;138(12):2145-51. doi: 10.1007/s00432-012-1296-x. Epub 2012 Aug 10. J Cancer Res Clin Oncol. 2012. PMID: 22878681
Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study.
Inal A, Ciltas A, Yildiz R, Berk V, Kos FT, Dane F, Unek IT, Colak D, Ozdemir NY, Buyukberber S, Gumus M, Ozkan M, Isikdogan A. Inal A, et al. Among authors: buyukberber s. Asian Pac J Cancer Prev. 2012;13(5):1841-4. doi: 10.7314/apjcp.2012.13.5.1841. Asian Pac J Cancer Prev. 2012. PMID: 22901133 Free article.
197 results